Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIV-711 PK and Food Effect in Healthy Volunteers
NCT03443453Phase 1Completed
- Sponsor
- Medivir
- Start
- Jan 2018
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of MIV-711 in osteoarthritis (OA) (2 arms), sponsored by Medivir. Primary endpoints: Area under the concentration-time curve from time 0 to the last observed non-zero concentration, Area under the concentration-time curve extrapolated to infinity and 4 more. Started Jan 2018; status: completed.
02
Drugs
MIV-711
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03443453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03443453.